Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
This article has been cited by
1TUFT1 promotes osteosarcoma cell proliferation and predicts poor prognosis in osteosarcoma patients
Yao-Ping Yu,Jian-Guo He,Ping Li,Ning-Hui Qiu,Li-Jun Wang,Hui Feng
Open Life Sciences.2018;13(1)396
2Risk and Prognostic Factors for Different Organ Metastasis in Primary Osteosarcoma: A Large Population-Based Analysis
Guijun Xu,Haixiao Wu,Yanting Zhang,Yao Xu,Xu Guo,Vladimir P. Baklaushev,Vladimir P. Chekhonin,Karl Peltzer,Jun Wang,Feng Lu,Guowen Wang,Xin Wang,Wenjuan Ma,Chao Zhang
Orthopaedic Surgery.2022;14(4)714
3The Proteasome Inhibitor Ixazomib Inhibits the Formation and Growth of Pulmonary and Abdominal Osteosarcoma Metastases in Mice
Michael A. Harris,Mark A. Miles,Tanmay M. Shekhar,Carmelo Cerra,Smitha R. Georgy,Stewart D. Ryan,Claire M. Cannon,Christine J. Hawkins
4Metastasis of Osteosarcoma to the Abdomen: A Report of Two Cases and a Review of the Literature
Robert Serpico,Jeffrey Brown,Alan Blank,Kevin Jones,R. Lor Randall,John Groundland
Case Reports in Oncology.2021;14(1)647
5Screening of disorders associated with osteosarcoma by integrated network analysis
Yongfeng Dou,Kai Zhu,Zhaozhong Sun,Xiaopeng Geng,Qingmin Fang
Bioscience Reports.2019;39(5)647
6LncRNA CBR3-AS1 promotes osteosarcoma progression through the network of miR-140-5p/DDX54-NUCKS1-mTOR signaling pathway
Weitao Yao,Jingyu Hou,Guoqing Liu,Fangxing Wu,Qiang Yan,Liangyu Guo,Chuchu Wang
Molecular Therapy - Oncolytics.2022;25(5)189

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal